-
1
-
-
0021038539
-
Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis
-
Teasley DG, Gerding DN, Olson MM, et al. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet 1983; 2:1043-1046.
-
(1983)
Lancet
, vol.2
, pp. 1043-1046
-
-
Teasley, D.G.1
Gerding, D.N.2
Olson, M.M.3
-
2
-
-
0030056217
-
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea
-
Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996; 22:813-818.
-
(1996)
Clin Infect Dis
, vol.22
, pp. 813-818
-
-
Wenisch, C.1
Parschalk, B.2
Hasenhundl, M.3
Hirschl, A.M.4
Graninger, W.5
-
3
-
-
0024492975
-
Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: Comparison of two dosage regimens
-
Fekety R, Silva J, Kauffman C, Buggy B, Deery HG. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989; 86:15-19.
-
(1989)
Am J Med
, vol.86
, pp. 15-19
-
-
Fekety, R.1
Silva, J.2
Kauffman, C.3
Buggy, B.4
Deery, H.G.5
-
4
-
-
0022491104
-
Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile
-
Bolton RP, Culshaw MA. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut 1986; 27:1169-1172.
-
(1986)
Gut
, vol.27
, pp. 1169-1172
-
-
Bolton, R.P.1
Culshaw, M.A.2
-
5
-
-
0018834545
-
Symptomatic relapse after oral vancomycin therapy of antibiotic- associated pseudomembranous colitis
-
Bartlett JG, Tedesco FJ, Shull S, Lowe B, Chang T. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology 1980; 78:431-434.
-
(1980)
Gastroenterology
, vol.78
, pp. 431-434
-
-
Bartlett, J.G.1
Tedesco, F.J.2
Shull, S.3
Lowe, B.4
Chang, T.5
-
6
-
-
0028226085
-
A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease
-
McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271:1913-1918.
-
(1994)
JAMA
, vol.271
, pp. 1913-1918
-
-
McFarland, L.V.1
Surawicz, C.M.2
Greenberg, R.N.3
Fekety, R.4
Elmer, G.W.5
Moyer, K.A.6
-
7
-
-
0030969261
-
Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis
-
American College of Gastroenterology, Practice Parameters Committee
-
Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92:739-750.
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 739-750
-
-
Fekety, R.1
-
8
-
-
84860081164
-
Drug therapy: Use of antimicrobial agents as first-line drug therapy for CDAD
-
Hurley, B. W. and Nguyen, C. C. Drug therapy: use of antimicrobial agents as first-line drug therapy for CDAD. PIER: Clinical Guidance from ACP, 2004. Available at: pier.acponline.org/physicians/diseases/d320/d320.html. Accessed on July 14, 2004.
-
(2004)
PIER: Clinical Guidance from ACP
-
-
Hurley, B.W.1
Nguyen, C.C.2
|